Respiratory Flashcards

1
Q

Causes of severe pulmonary oedema

A

CV: usually LVF (post-MI or IHD), valvular heart disease, arrhythmias, malignant HTN
ARDS from any cause: trauma, malaria, drugs, sepsis
Fluid overload (iatrogenic)
Neurogenic (e.g. head injury)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Ix for pulmonary oedema

A
CXR: ABCDE
ECG: signs of MI or dysrhythmias
UEC: troponin, ABG
Consider echo
Plasma BNP may be helpful if Dx is in question (high negative predictive value)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mx of pulmonary oedema (should be commenced before Ix)

A

Monitoring progress: BP, pulse, cyanosis, RR, JVP, urine output, ABGs
Once stable and improving: daily weights (aim for reduction of 0.5kg/day), QDS obs, repeat CXR, manage underlying cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

6 causes of pneumothorax

A

Spontaneous (esp in young thing men) due to rupture of subpleural bulla
Chronic lung disease (e.g. asthma, COPD, CF, lung fibrosis, srcoidosis)
Infection (e.g. TB, pneumonia, lung abscess)
Traumatic, including iatrogenic (e.g. CVP line insertion, pleural aspiration or biopsy, percutaneous liver biopsy, positive pressure ventilation)
Carcinoma
Connective tissue disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Signs of pneumothorax

A

Reduced chest expansion
Hyper-resonance to percussion and diminished breath sounds on affected sounds
If tension pneumothorax: deviation of trachea, respiratory distress, tachycardia, hypotension, distended neck veins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ix for pneumothorax

A

IF SUSPECT TENSION PNEUMOTHORAX, IMMEDIATE PLEUROCENTESIS IS INDICATED (do not delay for CXR; can do CXR later)
Expiratory plain film: look for area devoid of lung markings (ensure suspected pneumothorax is not a large emphysemous bulla)
ABG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mx of pneumothorax

A

Pleurocentesis
Chest drain (ICC) if secondary to trauma or mechanical ventilation, or if aspiration unsuccessful in a significant, symptomatic pneumothorax
Seek surgical advice if bilateral pneumothoraces, lung fails to expand after ICC insertion, recurrent pneumothoraces or Hx of pneumothorax on OPPOSITE side
FU: CXR after 24hrs and 7-10 days to exclude recurrence, avoid air travel for 6/52, avoid diving permanently

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Tension pneumothorax

A

Air drawn into pleural space with each inspiration has no route of escape during expiration; mediastinum is pushed over into contralateral hemithorax, kinking and compressing the great veins
Unless air is rapidly removed, cardiac arrest will occur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mx of tension pneumothorax

A

Pleurocentesis: large-bore (14-16G) needle with syringe, partially filled with 0.9% saline (acts as water seal), into 2nd intercostal space in midclavicular line (or 4-6th in midaxillary) on side of suspected pneumothorax

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Insertion of chest draina

A

Site: 4-6th intercostal space, anterior- to mid-axillary line
Removal: consider when drain is no longer bubbling and CXR shows re-inflation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

RFs for PE

A

Malignancy
Surgery (esp pelvic and lower limb; risk greatly reduced by DVT prophylaxis)
Immobility
Combined OCP (slight risk with HRT)
Previous thromboembolism and inherited thrombophilia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

CXR findings in PE

A

Often normal

May be decreased vascular markings,small pleural effusion, wedge-shaped area of infarction, atelectasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ix for PE

A

ABG: hypoxia, respiratory alkalosis
D-dimer: high sensitivity but low specificity (increased if thrombosis, inflammation, post-op, infection, malignancy), good to EXCLUDE PE
CTPA: sensitive and specific
V/Q: if CTPA unavailable or contraindicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mx of PE

A

O2 if hypoxic (10-15L/min)
Morphine
If critically ill with massive PE, consider immediate thrombolysis with alteplase
Otherwise: LMWH and warfarin until INR >2, compression stockings for prevention of further PE
FU: 6/52 warfarin if obvious remedial cause (otherwise consider >3-6/12 or long term if recurrent or underlying malignancy), Mx of underlying cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When is an IVC filter indicated?

A

When patients cannot be anticoagulated, or in case of recurrent VTE in patients who are optimally anticoagulated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Dx of TB

A

Latent: Mantoux, followed by Quantiferon Gold (measure IFN-y response to MTB) if positive
Active respiratory: sputum samples (>3, one early morning, before commencing treatment; try bronchoscopy and lavage if cannot obtain sample) with MCS for acid-fast bacilli on ZN staining
Active non-respiratory: try to get samples (sputum, pleura and pleural fluid, urine, pus, ascites, peritoneum, bone marrow, CSF) for MCS
PCR for rapid identification of MDR-TB
Histology: caseating granuloma
CXR findings: consolidation, cavitation, fibrosis, calcification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Mx of TB

A
2/12 of RIPE initially:
Rifampicin
Isoniazid
Pyrazinamide
Ethambutol
4/12 of RI to continue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

SEs of rifampicin

A

Increased LFTs (esp bilirubin)
Thrombocytopaenia
Orange discolouration of urine, tears and contact lens
Flu Sx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

SEs of isoniazid

A

Increased LFTs
Decreased WCC
Neuropathy (if this occurs, stop and give pyridoxine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

SEs of ethambutol

A

Optic neuritis (colour vision is first to deteriorate; test before commencing treatment and throughout FU)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

SEs of pyrazinamide

A

Hepatitis
Arthralgia
CI in gout and porphyria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Clinical features of TB

A

Pulmonary: cough, sputum, malaise, night sweats, haemoptysis
Miliary (following haematogenous dissemination): non-specific or overwhelming signs, consider lung, liver, LN or marrow biopsy
Genitourinary: LUTS, haematuria, sterile pyuria
Bone: vertebral collapse, Pot’s vertebra
Skin (lupus vulgaris): jelly-like nodules
Peritoneal: abdominal pain, GI upset
Acute TB pericarditis
Chronic pericardial effusion and constrictive pericarditis
TB meningitis: very poor prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Chemoprophylaxis for asymptomatic TB infection

A

1-2 anti-TB drugs for shorter periods (e.g. rifampicin and isoniazid for 3/12, or isoniazid alone for 6/12)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Malignant mesothelioma

A

Tumour of mesothelial cells that usually occurs in the pleura (rarely in peritoneum or other organs)
Associated with occupational exposure to asbestosis (latent period between exposure and deveopment of tumour may be up to 45 years)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Sx of mesothelioma

A
Chest pain
Dyspnoea
Weight loss
Finger clubbing
Recurrent pleural effusions
26
Q

Ix for mesothelioma

A

CXR: pleural thickening/effusion, may be pleural plaques if previous asbestosis

27
Q

Dx of mesothelioma

A

On histology, usually following a thoracoscopy

28
Q

Mx of mesothelioma

A

Chemotherapy: pemetrexed + cisplatin
Radiotherapy controversial
Pleurodesis and indwelling pleural drain may help Sx

29
Q

Prognosis of mesothelioma

A

Poor (without pemetrexed,

30
Q

Sarcoidosis

A

Multisystem granulomatous disorder of unknown cause

Usually affects adults aged 20-40

31
Q

Causes of bilateral hilar lymphadenopathy

A

Sarcoidosis
Infection (e.g. TB, mycoplasma)
Malignancy (e.g. lymphoma, carcinoma, mediastinal tumours)
Pneumoconioses, i.e. organic dust disease (e.g. silicosis, berylliosis)
Extrinsic allergic alveolitis
Histocytosis X

32
Q

Clinical features of sarcoidosis

A
Often asymptomatic (detected on CXR)
Acute: erythema nodosum, polyarthralgia
Pulmonary disease: dry cough, progressive exertional dyspnoea, chest pain
Non-pulmonary: lymphadenopathy, hepatosplenomegaly, uveitis, conjunctivitis, glaucoma, subcutaneous nodules, cardiomyopathy, arrhythmias, hypercalcaemia, neurosarcoidosis
33
Q

Ix for sarcoidosis

A

Increased ESR
Decreased WCC
Increased LFTs
Increased immunoglobulins
Increased Ca2+ (also calcuria)
Lung function: may be normal or show restrictive defect
Tissue biopsy is diagnostic: shows non-caseating granuloma

34
Q

Mx of sarcoidosis

A

With BHL alone: no need for treatment, most recover spontaneously
Acute: steroids
Indications for steroids: parenchymal lung disease, uveitis, hypercalcaemia, neurological or cardiac involvement (high dose pred for 4-6/52 then decrease over 1 year)
Anti-TNFa or lung transplant in refractory cases

35
Q

Prognosis of sarcoidosis

A

60% with thoracic sarcoidosis recover over 2 years
20% respond to steroid therapy
In rest, improvement is unlikely despite therapy

36
Q

DDx of granulomatous disease

A

Infections: bacterial (e.g. TB, leprosy, syphilis), fungal (e.g. cryptococcus)
AI: PBC
Vasculitis: GCA, polyarteritis nodosa, Takayasu’s arteritis, Wegener’s granulomatosis
Pneumoconioses: silicosis, berylliosis
Idiopathic: Crohn’s disease, de Quervain’s thyroiditis, sarcoidosis
Extrinsic allergic alveolitis
Histiocytosis X

37
Q

Causes of transudate pleural effusion

A

Increased venous pressure: HF, constrictive pericarditis, fluid overload
Decreased oncotic pressure: cirrhosis, nephrotic syndrome, malabsorption
Hypothyroidism

38
Q

Causes of exudate pleural effusion

A

Infection: pneumonia, TB
Inflammation: pulmonary infarction, RA, SLE
Malignancy: bronchogenic carcinoma, malignant metastases, lymphoma, mesothelioma, lymphangitis carcinomatosis

39
Q

Sx of pleural effusion

A

May be asymptomatic
Dyspnoea
Pleuritic chest pain

40
Q

Signs of pleural effusion

A
Decreased chest expansion
Stony dull percussion
Diminished breath sounds
Decreased vocal resonance and fremitus
May be bronchial breathing ABOVE the pleural effusion due to compression of the lung
Tracheal deviation if large effusion
41
Q

Ix of pleural effusion

A

CXR: costophrenic blunting
U/S: to identify presence of pleural fluid and guide diagnostic or therapeutic aspiration
Diagnostic aspiration: percuss the upper border of the pleural effusion, choose site 1-2 intercostal spaces below it, aspirate 10-30mL fluid through 21G needle and send to lab for clinical chemistry (protein, glucose, pH, LDH, amylase), MCS, cytology and if indicated immunology (e.g. RhF, ANA)
Pleural biopsy if analysis is inconclusive

42
Q

Mx of pleural effusion

A

Drainage if symptomatic (with chest drain if empyema)
Pleurodesis with tetracycline, bleomycin or talc if recurrent effusions (talc most useful for malignant effusions)
Surgery if persistent collections and increasing pleural thickness

43
Q

Interpretation of cytology of pleural fluid

A

Neutrophils ++: parapneumonic effusion (i.e. in pneumonia), PE
Lymphocytes ++: malignancy, TB, RA, SLE, sarcoidosis
Mesothelial cells ++: pulmonary infarction
Abnormal mesothelial cells: mesothelioma
Multinucleated giant cells: RA

44
Q

Interpretation of clinical chemistry of pleural fluid

A

Protein under 25g/L: transudate
Protein >35g/L: exudate
Glucose under 3.3mmol/L, pH under 7.2, raised LDH: empyema, malignancy, TB, RA, SLE
Increased amylase: pancreatitis, carcinoma, bacterial pneumonia, oesophageal rupture

45
Q

Lung abscess

A

Cavitating area of localised, suppurative infection within the lung

46
Q

Causes of lung abscess

A

Inadequately treated pneumonia
Aspiration (e.g. alcoholism, oesophageal obstruction, bulbar palsy)
Bronchial obstruction (tumour, foreign body)
Pulmonary infarction
Septic emboli (septicaemia, right heart endocarditis, IVDU)
Subphrenic or hepetic abscess

47
Q

Clinical features of lung abscess

A
Swinging fever
Cough productive of purulent, foul-smelling sputum
Pleuritic chest pain
Haemoptysis
Finger clubbing
48
Q

Bronchiectasis

A

Chronic infection of bronchi and bronchioles leading to permanent dilatation of these airways

49
Q

Main organisms in bronchiectasis

A

Haemophilus influenzae
Strep pneumoniae
Staph aureus
Pseudomonas aeruginosa

50
Q

Signs of bronchiectasis

A

Finger clubbing

Coarse inspiratory crepitations

51
Q

Cystic fibrosis

A

AR condition caused by mutations in CFTR gene

Defect in Cl- channel caudes defective chloride secretion and increased Na+ absorption

52
Q

Clinical features of CF

A

Respiratory: cough, wheeze, recurrent infections, bronchiectasis, pneumothorax, haemoptysis, respiratory failure, cor pulmonale
GI: pancreatic insufficiency (DM, steatorrhoea), gallstones, cirrhosis
Other: male infertility, OP, arthritis, vasculitis, nasal polyps, sinusitis

53
Q

Signs of CF

A

Cyanosis
Finger clubbing
Bilateral coarse crackles

54
Q

Mx of CF

A

Multidisciplinary involvement is indicated
Chest: physio regularly, Abx for acute infective exacerbations or prophylactically, mucolytics, bronchodilators
GI: pancreatic enzyme replacement, fat soluble vitamin supplements

55
Q

HPOA

A

Hypertrophic pulmonary osteoarthropathy (usually associated with lung cancer)

56
Q

Causes of ARDS

A

Pulmonary: pneumonia, aspiration, inhalation, injury, vasculitis, contusion
Trauma: haemorrhage, head injury, shock, burns
Septicaemia
DIC
Pancreatitis
Acute liver failure
Drugs/toxins: aspirin, heroin, paraquat

57
Q

Clinical features of ARDS

A
Cyanosis
Tachypnoea
Tachycardia
Peripheral vasodilatation
Bilateral fine inspiratory crackles
58
Q

Ix for ARDS

A

CXR: bilateral pulmonary infiltrates

PCWP to rule out HF

59
Q

Dx of ARDS

A

These 4 must exist:

1) Acute onset
2) CXR: bilateral infiltrates
3) PCWP less than 19mmHg or lack of clinical congestive HF
4) Refractory hypoxaemia

60
Q

Mx of ARDS

A

ICU admit
Give supportive therapy and treat underlying cause
Respiratory support: CPAP with O2 but most pts will require mechanical ventilation
Circulatory support: invasive haemodynamic monitoring with an arterial line and Swan-Ganz catheter (pulmonary artery catheterisation)

61
Q

Prognosis of ARDS

A

Mortality is 50-75%